| 标题 |
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet (London, England) 作者:Kudo M; Ren Z; Guo Y; Han G; Lin H; et al 出版日期:2025/01/18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)